Mim8, a novel factor VIIIa mimetic bispecific antibody, shows favorable safety and pharmacokinetics in healthy adults
Mim8是一种新型的VIIIa因子模拟双特异性抗体，在健康成人中显示出良好的安全性和药代动力学特性。
期刊:Research and Practice in Thrombosis and Haemostasis
影响因子:3.4
doi:10.1016/j.rpth.2023.102181
Persson, Paula; Amstrup, Anne-Beth; Coester, Hans Veit; Matytsina, Irina; Bas, Selcuk
